Bioavailability enhancers of herbal origin: An overview

Asian Pacific Journal of Tropical Biomedicine

Volumn 3, Issue 4, 2013, Pages 253-266

  Kesarwani, Kritika ^a   Gupta, Rajiv ^a  

^a BABU BANARASI DAS NATIONAL INSTITUTE OF TECHNOLOGY AND MANAGEMENT   (India)

Author keywords

Bioavailability; Bioenhancer; Formulation; Herbal; Nanotechnology; Novel Drug Delivery System

Indexed keywords

ALOE VERA EXTRACT; AMPICILLIN; AURANTIIN; CAPSAICIN; CARBAMAZEPINE; COLCHICINE; CURCUMIN; CYTOCHROME P450 3A2; CYTOCHROME P450 3A4; DILTIAZEM; EMODIN; EPIGALLOCATECHIN GALLATE; ETHOSOME; GARLIC EXTRACT; GENISTEIN; GINGER EXTRACT; GLYCOPROTEIN P INHIBITOR; GLYCYRRHIZIC ACID; LIPOSOME; MICROSPHERE; MULTIDRUG RESISTANCE PROTEIN; NANOPARTICLE; PACLITAXEL; PAEONIFLORIN; PIPERINE; PLACEBO; PLANT EXTRACT; QUERCETIN; TRANSFEROSOME; UNCLASSIFIED DRUG; UNINDEXED DRUG; DRUG; LIPID;

ARTHRITIS; ARTICLE; BIOSYNTHESIS; BREAST CANCER; DEPRESSION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DEVELOPMENT; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG INHIBITION; DRUG MANUFACTURE; DRUG MECHANISM; EPILEPSY; FIRST PASS EFFECT; HUMAN; INFLAMMATION; LIPID SOLUBILITY; LOW DRUG DOSE; MOLECULAR SIZE; NANOTECHNOLOGY; NONHUMAN; OVARY CANCER; PANCREATITIS; PARTICLE SIZE; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; BIOAVAILABILITY; CHEMISTRY; HERBAL MEDICINE; MEDICINAL PLANT; SOLUBILITY;

BIOLOGICAL AVAILABILITY; DRUG DELIVERY SYSTEMS; HERBAL MEDICINE; HUMANS; LIPIDS; NANOPARTICLES; NANOTECHNOLOGY; PHARMACEUTICAL PREPARATIONS; PLANT EXTRACTS; PLANTS, MEDICINAL; SOLUBILITY;

EID: 84875487885     PISSN: 22211691     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2221-1691(13)60060-X     Document Type: Article

References (143)

1. Acharya SN, Parihar VG, Acharya RS Hytosomes: novel approach for delivering herbalextract with improved bioavailability. Int J Pharm Sci 2011, 2:144-160.
2. Patwardhan B, Mashelkar RA Traditional medicine-inspired approaches to drug discovery and development: can Ayurveda show a way forward?. Drug Discov Today 2009, 14:804-811.
3. Manach C, Scalbert A, Morand C Polyphenols: food sources and bioavailability. Am J Clin Nutr 2004, 79:727-747.
4. Uchegbu IF, Vyas SP Non ionic surfactant based vesicles (Niosomes) in drug delivery. Int J Pharma 1998, 172:33-70.
5. Moussaoui N, Cansell M, Denizot A Marinosomes, marine lipid-based liposomes: physical characterization and potential application in cosmetics. Int J Pharma 2002, 242:361-365.
6. Atal CK A breakthrough in drug bioavailability-a clue from age old wisdom of Ayurveda. IDMA Bulletin 1979, 10:483-484.
7. Johri RK, Zutshi U An Ayurvedic formulation 'Trikatu' and its constituents. J Ethnopharmacol 1992, 37:85-91.
8. Shaikh J, Ankola DD, Beniwal V, Singh D, Kumar MN Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur J Pharm Sci 2009, 37:223-230.
9. Hayton WL Low dose ethanol in the treatment of ethylene glycol poisoning. J Vet Pharmacl Ther 1985, 8:254-262.
10. Veiga F, Fernandes C, Teixeira F Oral bioavailability and hypoglycaemic activity of tolbutamide/cyclodextrin inclusion complexes. Int J Pharm 2000, 202:165-171.
11. Schinkel AH, Jonker JW Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv Drug Del Rev 2003, 55:3-29.
12. Juliano RL, Ling L P-glycoprotein, a type of ATPase and an energy dependent trans membrane drug efflux pump, Biochem. Biophys Acta 1976, 555:152-162.
13. Lundin S, Artursson P Absorption enhancers as an effective method in improving the intestinal absorption. Int J Pharm 1990, 64:181-186.
14. Aungst BJ, Blake JA, Hussain MA An invitro evaluation of metabolism and poor membrane permeation impeding intestinal absorption of leucine enkephalin and methods to increase absorption. J Pharmacol Exp Ther 1991, 259:139-145.
15. Schipper NGM, Olsson S, Hoogstraate JA, Boer AG, Varum KM, Artursson P Chitosan an absorption enhancers for poorly absorbable drugs: influence of molecular weight and degree of acetylation on derug transport acroos human intestinal epithelial (Caco-2) cells. Pharm Res 1997, 113:1686-1692.
16. Buur A, Bundgaard H, Falch E Prodrugs of 5-fluorouracil. VII. Hydrolysis kinetics and physicochemical properties of N-ethoxy- and N-phenoxycarbonyloxymethyl derivatives of 5-fluorouracil. Acta Pharm Suec 1986, 23:205-216.
17. Patel HM, Ryman BE The gastrointestinal absorption of liposomally entrapped insulin in normal rats. Biochem Soc Trans 1977, 5:1054-1055.
18. Engel RH, Riggi SJ, Fahrenbach MJ Insulin: intestinal absorption as oil-in-water-in-water emulsions. Nature 1968, 219:856-857.
19. Liversidge GG, Cundy KC Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: Absolute oral bioavailability of nanocrystalline danazol in beagle dogs. Int J Pharm 1995, 125:91-97.
20. Veiga F, Fernandes C, Teixeira F Oral bioavailability and hypoglycaemic activity of tolbutamide/cyclodextrin inclusion complexes. Int J Pharm 2000, 202:165-171.
21. Varma MV, Ashokraj Y, Dey CS, Panchagnula R P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement. Pharmacol Res 2003, 48:347-359.
22. Annamalai AR, Manavalan R Effects of Trikatu and its individual components and piperine on gastrointerstinal tracts: Trikatua bioavailable enhancer. Ind Drugs 1989, 27(12):595-604.
23. Bajad S, Bedi KS, Singla AK, Johri RK Piperine inhibits gastric emptying and gastrointestinal transit in rats and mice. Planta Med 2001, 67:176-179.
24. Majeed M, Badmaev V, Rajendran R. Use of piperine to increase the bioavailability of nutritional compounds. United States Patent, Number 5536506. 1995.
25. Khajuria A, Thusu N, Zutshi U Piperine modulates permeability characteristics of intestine by inducing alterations in membrane dynamics: influence on brush border membrane fluidity, ultrastructure and enzyme kinetics. Phytomed 2002, 9:224-231.
26. Reanmongkol W, Janthasoot W, Wattanatorn W, Upakorn PD, Chudapongse P Effects of Piperine on bioenergetics functions of isolated rat liver mitochondria. Biochem Pharmacol 1988, 37:753-757.
27. Atal CK, Dubey RK, Singh J Biochemical basis of enhanced drug bioavailability by piperine: evidence that piperine is a potent inhibitor of drug metabolism. J Pharmacol Exp Therap 1985, 232:258-262.
28. Johri RK, Thusu N, Khajuria A, Zutshi U Piperine mediated changes in the permeability of rat intestinal epithelial cells: Status of gamma glutamyl transpeptidase activity, uptake of amino acids and lipid peroxidation. Biochem Pharmacol 1992, 43:1401-1407.
29. Bajad S, Bedi KL, Singla AK, Johri RK Piperine inhibits gastric emptying and gastrointestinal transit in rats and mice. Planta Med 2001, 67:176-179.
30. Atal CK, Dubey RK, Singh J Biochemical basis of enhanced drug bioavailability by piperine: evidence that piperine is a potent inhibitor of drug metabolism. J Pharmacol Exp Ther 1985, 232:258-262.
31. Singh J, Dubey RK, Atal CK Piperine-mediated inhibition of glucuronidation activity in isolated epithelial cells of the guinea-pig small intestine: evidence that piperine lowers the endogeneous UDP-glucuronic acid content. J Pharmacol Exp Ther 2002, 302:645-650.
32. Bhardwaj RK, Glaeser H, Becquemont L, Klotz U, Gupta SK, Fromm MF Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4. J Pharmacol Exp Ther 2002, 302:645-650.
33. Khajuria A, Zutshi U, Bedi KL Permeability characteristics of piperine on oral absorption - An active alkaloid from peppers and a bioavailability enhancer. Ind J Exp Biol 1998, 36:46-50.
34. Wagner V, Dullaart A, Bock A-K, Zweck A The emerging nanomedicine landscape. Nat Biotech 2006, 24(10):1211-1217.
35. Nijveldt RJ, Nood EV, van Hoorn DEC, Boelens PG, Norren K, van Leeuwen PAM Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr 2001, 74:418-425.
36. Hoi JS, Li X Enhanced diltiazem bioavailability after oral administration of diltiazem with quercetin to rabbits. Int J Pharm 2005, 297:1-8.
37. Dupuy J, Larrieu G, Sutra JF, Lespine A, Alvinerie M Enhancement of moxidectin bioavailability in lamb by a natural flavonoid: quercetin. Vet Parasitol 2003, 112:337-347.
38. Wang YH, Chao PD, Hsiu SL, Wen KC, Hou YC Lethal quercetin-digoxin interaction in pigs. Life Sci 2004, 74:1191-1197.
39. Anup K, Sonia G, Swati K, Shrirang N, Waheed R, Vadim I, et al. The studies on bioenhancer effect of red onions and other nutrients on the absorption of epigallocatechin gallate from green tea extract in human volunteers. Boston: 2nd International Conference on Tumor Progression & Therapeutic Resistance Proceedings; 2005, p. 89.
40. Pichard LG, Gillet G, Fabre I, Dalet-Beluche I, Bonfils C, Thenot JP Identification of the rabbit and human cytochromes P-450IIIA as the major enzymes involved in the Ndemethylation of diltiazem. Drug Metab Dispos 1991, 18:711-719.
41. Molden E, Asberg A, Christensen H Desacetyl-diltiazemm displays several fold higher affinity to CYP2D6 compared with CYP3A4. Drug Metab Dispos 2002, 30:1-3.
42. Yusa K, Tsuruo T Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells. Cancer Res 1989, 49:5002-5006.
43. Saeki T, Ueda K, Tanigawara Y, Hori R, Komano T Pglycoprotein-mediated transcellular transport of MDR-reversing agents. FEBS Lett 1993, 324:99-102.
44. Scambia G, Ranelletti FO, Panici PB, De Vincenzo R, Bonanno G, Ferrandina G, et al. Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target. Cancer Chemother Pharmacol 1994, 34:459-464.
45. Shapiro AB, Ling V Effect of quercetin on Hoechst 33342 transport by purified and reconstituted p-glycoprotein. Biochem Pharmacol 1997, 53:587-596.
46. Miniscalco A, Landahl J, Regardh CG, Edgar B, Eriksson UG Inhibition of dihydropyridine in rat and human liver microsomes by flavonoids found in grapefruit juice. J Pharmacol Exp Ther 1992, 261:1195-1198.
47. Kurzer M, Xu X Dietary phytoestrogens. Annu Rev Nutr 2003, 17:353-381.
48. Sparreboom A, van Asperen J, Mayer U, Schinkel AH, Smit JW, Meijer DK, et al. Limited oral bioavailability and active epithelial excretion of paclitaxel (taxol) caused by P-glycoprotein in the intestine. Proc Natl Acad Sci 1997, 4:2031-2035.
49. Doyle LA, Ross DD Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). J Oncogene 2003, 22:7340-7358.
50. Huisman MT, Chhatta AA, Tellingen OV, Beijnen JH, Schinkel AH MRP2 (ABCC2) transports taxanes and confers paclitaxel resistance and both processes are stimulated by probenecid. Int J Cancer 2005, 116:824-829.
51. Li X, Choi JS Effect of genistein on the pharmacokinetics of paclitaxel administered orally or intravenously in rats. Int J Pharm 2007, 337:188-193.
52. Zhang H, Wong CW, Coville PF, Wanwimolruk S Effect of the grapefruit flavonoid naringin on pharmacokinetics of quinine in rats. Drug Metabol Drug Interact 2000, 17:351-363.
53. Lim SC, Choi JS Effects of naringin on the pharmacokinetics of intravenous Paclitaxel in rats. Biopharm Drug Dispos 2006, 27:443-447.
54. Cheng SS, Fu SX, Li YS, Wang NC The pharmacology of sinomenine I: the analgesic and anti-phlogistic actions and acute toxicity. Acta Pharmacol Sin 1964, 4:177-180.
55. Takeda S, Isono T, Wakui Y, Matsuzaki Y, Sasaki H, Amagaya S, et al. Absorption and excretion of paeoniflorin in rats. J Pharm Pharmacol 1995, 47:1036-1040.
56. Liu ZQ, Zhou H, Liu L, Jiang ZH, Wong YF, et al. Influence of co-administrated sinomenine on pharmacokinetic fate of paeoniflorin in unrestrained conscious rats. J Ethnopharmacol 2005, 13:61-67.
57. Chan K, Liu XZ, Jiang ZH, Zhou H, Wong YF, Xu HX, et al. The effects of sinomenine on intestinal absorption of paeoniflorin by the everted rat gut sac model. J Ethnopharmacol 2006, 20:425-432.
58. Imai T, Sakai M, Ohtake H, Azuma H, Otagiri M Absorption enhancing effect of glycyrrhizin induced in the presence of capric acid. Int J Pharm 2005, 27:11-21.
59. Sakai M, Imai T, Ohtake H, Azuma H, Otagiri M Simultaneous use of sodium deoxycholate and dipotassium glycyrrhizinate enhances the cellular transport of poorly absorbed compounds across Caco-2 cell monolayers. J Pharm Pharmacol 1999, 51:27-33.
60. Khanuja SPS, Arya JS, Tiruppadiripuliyur RSK, Saikia D, Kaur H, Singh M. Nitrile glycoside useful as a bioenhancer of drugs and nutrients, process of its isolation from Moringa oleifera. United States Patent 6. 2006.
61. Zargari A Medicinal plants 1989, vol. II:519-521. Tehran University Press, Tehran.
62. Qazi GN, Bedi KL, Johri R, Tikoo MK, Tikoo AK, Sharma SC, et al. Bioavailability/bioefficacy enhancing activity of Cuminum cyminum and extracts and fractions thereof. United States Patent 7514105. 2009.
63. Boumendjel A, Di Pietro A, Dumontet C, Barron D Recent advances in the discovery of flavonoids and analogs with high-affinity binding to P-glycoprotein responsible for cancer cell multidrug resistance. Med Res Rev 2002, 22:512-529.
64. Qazi GN, Tikoo GL, Gupta AK, Ganjoo SK, Gupta DK, Jaggi BS, et al, inventor. Bioavailability enhancing activity of Zingiber officinale and its extracts/fractions thereof. European Patent Number EP 1465646. 2002.
65. Khanuja SPS, Arya JS, Srivastava SK, Shasany AK, Kumar S, Ranganathan T, et al, inventor. Antibiotic pharmaceutical composition with lysergol as bio-enhancer and method of treatment. United States Patent, Number 20070060604. 2006.
66. Ogita A, Fujita K, Taniguchi M, Tanaka T Enhancement of the fungicidal activity of amphotericin B by allicin, an allyl-sulfur compound from garlic, against the yeast Saccharomyces cerevisiae as a model system. Planta Med 2006, 72:1247-1250.
67. Vinson JA, Kharrat HA, Andreoli L Effect of Aloe vera preparations on the human bioavailability ofvitami C and E. Phytother Phytopharmacol 2005, 12:760-765.
68. Aroonsri P, Jintanaporn W, Saengrawee S, Wathita P, Supaporn M Applications of novel drug delivery system for herbal formulations. Nanomed Nanotechnol Biol Med 2008, 4:70-78.
69. Samaligy MS, Afifi NN, Mahmoud EA Evaluation of hybrid liposomes-encapsulated silymarin regarding physical stability and in vivo performance. Int J Pharm 2006, 319:121-129.
70. Chiara S, Alessandro DL, Francesco L, Donatella V, Maria M, Giuseppe L Preparation and characterization of Artemisia arborescens liposomes. Eur J Pharm Biopharm 2005, 59:161-168.
71. He ZF, Liu DY, Zeng S, Ye JT Study on preparation of Ampelopsin liposomes. J Chine Mat Med 2008, 33:27-30.
72. Rane S, Prabhakar B Influence of liposome composition on paclitaxel entrapment and Ph sensitivity of liposomes. Int J Pharm Technol Res 2009, 1:914-917.
73. Hong W, Chen DW, Zhao XL, Qiao MX, Hu HY Preparation and study in vitro of long-circulating nanoliposomes of curcumin. China J Chine Mat Med 2008, 33:988-992.
74. Sun P, Den SH, Yu WP Evaluation of garlicin liposomes. J Shan Univ TCM 2007, 31:37-39.
75. Xiao L, Zhang YH, Xu JC, Jin XH Preparation of floating rutin-alginate-chitosan microcapsule. Chine Trad Herb Drugs 2008, 2:209-212.
76. You J, Cui F, Han X, Wang Y, Yang L, Yu Y Zedoary oil microspheres. Colloids Surf B 2006, 48:35-41.
77. Machida Y, Onishi H, Kurita A, Hata H, Morikawa A, Machida Y Pharmacokinetics of prolonged-release CPT-11-loaded microspheres in rats. J Control Release 2000, 66:159-175.
78. Chao P, Deshmukh M, Kutscher HL, Gao D, Rajan SS, Hu P Pulmonary targeting microparticulate camptothecin delivery system: invitro hydrolysis and A549 human lung carcinoma cell toxicity. Anticancer Drugs 2010, 21:65-76.
79. Gavini E, Alamanni MC, Cossu M, Giunchedi P Tabletted microspheres containing Cynara scolymus extract for the preparation of controlled release nutraceutical matrices. J Microencapsul 2005, 22:487-499.
80. Zhinan M, Huabing C, Ting W, Yajiang Y, Xiangliang Y Solid lipid nanoparticle and microemulsion for topical delivery of triptolide. Eur J Pharm Biop Harm 2003, 56:189-196.
81. Feng-Lin Y, Tzu-Hui W, Liang-Tzung L, Thau-Ming C, Chun-Ching L Preparation and characterization of Cuscuta chinensis nanoparticles. Food Chem Toxicol 2008, 46:1771-1777.
82. Youfang C, Xianfu L, Hyunjin P, Richard G Evaluation of artemisnin nanoparticles. Nanomed Nanotechnol Biol Med 2009, 5:316-322.
83. Su YL, Fu ZY, Zhang JY, Wang WM, Wang H, Wang YC Preparation of Radix salvia nanoparticles. Powder Technol 2008, 184:114-121.
84. Fu RQ, He FC, Meng DS, Chen L Taxol PLA nanoparticles. Acta Academiae Medicinae Militaris Tertiae 2006, 28:1573-1574.
85. Lin AH, Li HY, Liu YM, Qiu XH Characterisation of berberine nanoparticles. China Pharm 2007, 18:755-757.
86. Feng-Lin Y, Tzu-Hui W, Liang-Tzung L, Thau-Ming C, Chun-Ching L Preparation of naringenin nanoparticles. Pharm Res 2009, 26:893-902.
87. Shiv Shankar S, Rai A, Ahmad A, Sastry M Rapid synthesis of Au, Ag and bimetallic Au core-Ag shell nanoparticles using Neem (Azadirachta indica) leaf broth. J Colloid Inter Sci 2004, 275:496-502.
88. Huang J, Li Q, Sun D, Lu Y, Su Y, Yang X, et al. Biosynthesis of silver and gold nanoparticles by novel sundried Cinnamomum canphora leaf. Nanotechnol 2007, 18:1-11.
89. Chandra PS, Chaudhary M, Pasricha R, Ahmad A, Sastry M Synthesis of gold nanotriangles and silver nanoparticles using Aloe vera plant extract. Biotechnol Prog 2006, 22:577-583.
90. Xiao YL, Luo JB, Yan ZH, Rong HS, Huang WM Preparation and invitro and invivo evaluations of topically applied capsiacin transferosomes. Yao Xeu Xeu Bao 2006, 41:461-466.
91. Singh HP, Utreja P, Tiwary AK, Jain S Elastic liposomal formulation for sustained delivery of colchicine: in vitro characterization and in vivo evaluation of anti-gout activity. AAPS J 2009, 2:54-64.
92. Zheng Y, Hou SX, Chen T, Lu Y Preparation and characterization of transfersomes of three drugs in vitro. China J Chin Mater Med 2006, 31:728-731.
93. Vandana SP, Suresh RN Cardioprotective activity of Ginkgo biloba phytosomes in isoproterenol-induced myocardial necrosis in rats: A biochemical and histopathological approach. Exp Toxicol Pathol 2008, 60:397-404.
94. Yanyu X, Yunmei S, Zhipeng C, Quineng P The preparation of silybin-phospholipid complex and the study on its pharmacokinetics in rats. Int J Pharm 2006, 307:77-82.
95. Bhattacharya S, Ghosh A Phytosomes: the emerging technology for enhancement of bioavailability of botanicals and nutraceuticals. Inter J Aes Anti Med 2009, 2:1.
96. Maiti K, Mukherjee K, Gantait A, Ahamed HN, Saha BP, Mukherjee PK Enhanced therapeutic benefit of quercetin-phospholipid complex in carbon tetrachloride-induced acute liver injury in rats: a comparative study. Iran J Pharmacol Thera 2005, 4:84-90.
97. Maiti K, Mukherjee K, Gantait A, Saha BP, Mukherjee PK Curcumin-phospholipid complex: Preparation, therapeutic evaluation and pharmacokinetic study in rats. Int J Pharm 2007, 330:155-163.
98. Maiti K, Mukherjee K, Gantait A, Bishnu PS, Mukherjee PK Enhanced therapeutic potential of naringenin-phospholipid complex in rats. J Pharm Pharmacol 2006, 58:1227-1233.
99. Zhaowu Z, Xiaoli W, Yangdel Z, Nianfeng L Matrine ethosomes. J Liposome Res 2009, 19:155-162.
100. Paolino D, Lucania G, Mardente D, Alhaique F, Fresta M Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers. J Cont Rel 2005, 106:99-110.
101. Goyal A, Kumar S, Nagpal M, Singh I, Arora S Potential of novel drug delivery systems for herbal drugs. Ind J Pharma Edu Res 2011, 45:231.
102. Kheradmandnia S, Farahani VE, Nosrati M, Atyabi F Preparation and characterization of ketoprofen loaded solid lipid nanoparticles made from beeswax and carnauba wax. Nano: Nano. Bio Med 2010, 6:753-759.
103. Martins MS, Wendling T, Gonclave FM, Sarmento B, Ferreira D Development and validation of simple reversed phase HPLC method for the determination of camptothesin in animal organs following administration of solid lipid nanoparticles. J Chroma B 2012, 880:100-107.
104. Tiyaboonchai W, Tungpradit W, Plianbangchang P Formulation and characterization of curcuminoids loaded solid lipid nanoparticles. Int J Pharma 2007, 337:299-306.
105. Wang S, Chen T, Ruie C, Hu Y, Chen M, Wang Y Emodin loaded solid lipid nanoparticles: preparation, characterization and anti tumour activity studies. Int J Pharma 2012, 430:238-246.
106. Kwon KT, Lim BK, Kim CT Solid lipid nanoparticles coated with silk fibroin. J Ind Eng Chem 2011, 17:10-13.
107. Kuchler S, Wolf BN, Heilmann S, Weindl G, Helfmann J, Yahya MM, et al. 3D wound healing model: influence of morphine and solid lipid nanoparticles. J Biotech 2010, 148:24-30.
108. Yuan H, Miao J, Du ZY, You J, Hu QF, Zeng S Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549cancer cells. Int J Pharma 2008, 248:137-145.
109. Chen H, Chang X, Du D, Liu W, Liu J, Kieng T, Yang Y, Xu H, Yang X Podophyllotoxin loaded solid lipid nanoparticles for epidermal targeting. J Cont Rel 2006, 110:296-306.
110. Jenning V, Gysler A, Korting SM, Gehla HS Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin. Euro J Pharma Biopharma 2000, 49:211-218.
111. Atal CK, Dubey RK, Singh J Biochemical basis of enhanced drug bioavailability by piperine. J Pharmacol Exp Ther 1985, 232:258-262.
112. Bano G, Amla V, Raina RK, Zutshi U, Chopra CL The effect of piperine on pharmacokinetics of phenytoin in healthy volunteers. Planta Med 1987, 53:568-569.
113. Debabrata C, Kruna S, Pal A, Luqman S Safety evaluation of Trikatu, a generic Ayurvedic medicine in Charles Foster rats. J Toxicological Sci 2009, 34:99-108.
114. Karan RS, Bhargava VK, Garg SK Effect of trikatu on the pharmacokinetic profile of indomethacin in rabbits. Ind J Pharmacol 1999, 31:160-161.
115. Bhatt PS, Chaudhary M, Pasricha R, Ahmad A, Sastry M Synthesis of gold nanotriangles and silver nanoparticles using Aloe vera plant extract. Biotech Prog 2006, 22:577-583.
116. Singh M, Varshneya C, Telang RS, Srivastava AK Alteration of pharmacokinetics of oxytetracycline following oral administration of Piper longum in hens. J Vet Sci 2005, 6:197-200.
117. Kang MJ, Cho JY, Shim BH, Kim DK, Lee J Bioavailability enhancing activities of natural compounds from medicinal plants. J Med Plants Res 2009, 3:1204-1211.
118. Pattanaik S, Hota D, Prabhakar P, Pandhi P Effect of simultaneous administration of piperine on plasma concentration of carbamazepine. Phytother Res 2009, 12:264-269.
119. Bhutani MK, Bishnoi M, Kulkarni SK Studies on antidepressant effect of curcumin with piperine pharmacol. Biochem Behavior 2009, 92:39-43.
120. Kulkarni SK, Bhutani MK, Bishnoi M Anti-depressant like effect of curcumin and its combination with piperine in unpredictable chronic stress-induced behavioral, biochemical and neurochemical changes. Pharmacol Biochem Behav 2009, 92:39-43.
121. Nirala SK, Bhadauria M, Mathur R, Mathur A Influence of alpha-tocopherol, propolis and piperine on therapeutic potential of tiferron against beryllium induced toxic manifestations. J Appl Toxicol 2008, 28:44-54.
122. Zhao JQ, Du GZ, Xiong YC, Wen YF, Bhadauria M, Nirala SK Attenuation of beryllium induced hepatorenal dysfunction and oxidative stress in rodents by combined effect of gallic acid and piperine. Arch Pharm Res 2007, 30:1575-1583.
123. Kasibhatta R, Naidu MU Influence of piperine on the pharmacokinetics of nevirapine under fasting conditions. Drugs Res Dev 2007, 8:383-391.
124. Durgaprasad S, Pai CG, Vasanthkumar, Alvres JF, Namitha S A pilot study of the antioxidant effect of curcumin in tropical pancreatitis. Ind J Med Res 2005, 122:315-318.
125. Lambert JD, Kong J, Kim DH, Mishim VM, Yang CS Piperine enhances the bioavailability of the tea polyphenol (-)-epigallocatechin-3-gallate in mice. J Nutr 2004, 134:1948-1952.
126. Badmaev V, Majeed M, Prakash L Piperine derived from black pepper increases the plasma levels of coenzyme Q10 following oral supplementation. J Nutr Biochem 2000, 11:109-113.
127. Majeed M, Badmaev V, Rajendran R, inventors. Use of piperine to increase the bioavailability of nutritional compounds. United States Patent, Number 5536506. 1995.
128. Kumari A, Yadav KS, Pakade DY, Kumar V, Singh B, Chaudhary A, et al. Nanoencapsulation and characterization of Albizia chinensis isolated antioxidantquercitrin on PLA nanoparticles. Coll Surf B: Biointer 2011, 82:224-232.
129. Niraimathi KL, Sudha V, Lavanya R, Brindha P Biosynthesis of silver nanoparticles using Alternanthera sessilis (Linn.) extract and their antimicrobial, antioxidant activities. Coll Surf B: Biointer 2010, 42:1-20.
130. Sahni KJ, Doggui S, Ali J, Baboota S, Dao L, Ramassamy C Neurotherapeutic applications of nanoparticles in Alzheimer's disease. J Con Rel 2011, 152:108-231.
131. Aromal SA, Babu DVK, Philip D Characterization and catalytic activity of gold nanoparticles synthesized using ayurvedic arishtams. Spectro Acta Part A: Mol Biomol Spectro 2012, 10.1016/j.saa.2012.08.010.
132. Khalil MHM, Ismail HE, Magdoub F Biosynthesis of Au nanoparticles using olive leaf extract. Arab J Chem 2010, 10.1016/j.arabjc.2010.11.011.
133. Jeevitha D, Amarnath K Chitosan/PLA nanoparticles as a novel carrier for the delivery of anthraquinone: Synthesis, characterization and in vitro cytotoxicity evaluation. Coll Surf B: Biointer 2010, 101:126-134.
134. Pahri P, Mohanty C, Sahoo SK Nanotechnology based combinational drug delivery: an emerging approach for cancer drug therapy. Dr Dis To 2012, 17:17-18.
135. Rajendran R, Radhai R, Kotresh TM, Csiszar E Development of antimicrobial cotton fabrics using herb loaded nanoparticles. Carbo Poly 2010, 10.1016/j.carbpol.2012.08.064.
136. Yallapu MM, Jaggi M, Chauhan CS Curcumin nanoformulation: a future nanomedicine for cancer. Dr Dis To 2012, 17:1-2.
137. Chaudhary Q, Castle L Food applications of nanotechnologies: An overview of opportunities and challenges for developing countries. Tren Food Sci Tech 2011, 22:595-603.
138. Li L, Wang H, Ong YZ, Xu K, Ee RLP, Zheng S, et al. Polymer- and lipid-based nanoparticle therapeutics for the treatment of liver diseases. Nano Tod 2010, 5:296-312.
139. Jain N, Jain KG, Javed S, Iqbal Z, Talegaonkar S, Ahmad F, et al. Recent approaches for the treatment of periodontitis. Dr Dis To 2008, 13:21-22.
140. Suryawanshi SJA Phytosome: An emerging trend in herbal drug treatment. J Med Gene Geno 2011, 3:109-114.
141. Priprem P, Watanatorn J, Sutthiparianout S, Pachonpai W, Muchimapura S Anxiety and cognitive effects of quercetin liposomes in rats. Nanomed Nanotech Bio Med 2008, 4:70-78.
142. Yilmaz M, Turkdemir H, Kilic AM, Bayram E, Cicek A, Mete A, et al. Biosynthesis of silver nanoparticles using leaves of Stevia rebaudiana. Mat Chem Phy 2011, 130:1195-1202.
143. Phillipi C, Loretz B, Schaefer FU, Lehr MC Telomerase as an emerging target to fight cancer: Opportunities and challenges for nanomedicine. J Con Rel 2010, 146:228-240.